LEO 32731
Sponsors
LEO Pharma
Conditions
Drug Interaction PotentiationHealthyHealthy SubjectsPsoriasis Vulgaris
Phase 1
LEO 32731 - A Study in Healthy Male Subjects
CompletedNCT01310049
Start: 2011-03-31End: 2012-11-30Updated: 2013-11-05
A Phase I Study With LEO 32731 and Midazolam in Healthy Male Subjects
TerminatedNCT02753218
Start: 2016-04-30End: 2016-05-31Updated: 2017-05-03
Open-label, Single Center, Non-randomized, Fixed Sequence Phase 1 Drug-drug Interaction Study With LEO 32731 and Midazolam
CompletedNCT03126578
Start: 2017-05-31End: 2017-10-20Updated: 2017-11-14
Multiple Dose Study With Incremental Dosing to Evaluate the Safety, Tolerability, and Pharmacokinetics of Oral Doses of LEO 32731 in Healthy Male Japanese Subjects.
CompletedNCT03231124
Start: 2017-07-25End: 2017-08-22Updated: 2021-06-29
A Trial to Investigate the Safety, Tolerability, and Drug Levels in Blood After Single and Multiple Doses of LEO 32731 in Healthy People
CompletedNCT03812198
Start: 2019-01-22End: 2019-06-13Updated: 2019-07-01